Mounjaro is the first dual GIP/GLP-1 receptor agonist, producing average weight loss exceeding 20% in some trials. It is administered as a once-weekly injection under medical supervision.
At Atlanta Medical Institute, our Mounjaro program is fully physician-supervised with personalized titration, lab monitoring, and nutritional support.
The Dual-Action Advantage
Mounjaro is the first medication to combine GLP-1 and GIP receptor activation. The result is enhanced appetite suppression, improved insulin sensitivity, and superior weight loss compared to GLP-1-only therapies.
What to Expect
Patients start at a low dose with gradual titration. Most see meaningful appetite changes within 1–2 weeks. We monitor labs, blood pressure, and weight throughout the program.
Patient Reviews
"Down 52 lbs in 6 months. The Mounjaro protocol completely changed my relationship with food."
Related Patient Videos
Ready to Get Started?
Call us at (404) 341-4819 or book a telehealth consultation. New patients qualify for our 1st month Semaglutide special — $275 (regularly $450).